Colgate-PalmoliveCorteva
Live Report · Updated 12 June 2026

Colgate-Palmolive vs Corteva

Global oral care and household products leader vs Global agricultural company supplying seeds and crop protection. Which is the better buy for your portfolio in June 2026? Plain-English answer below.

Colgate-Palmolive sells toothpaste, soap, and household products to billions of consumers across developed and emerging markets with a brand portfolio that's defended shelf space for generations, whil...

Why It’s Moving

Colgate-Palmolive

Colgate-Palmolive is sliding on valuation worries as analysts flag limited upside and a possible 8% downside.

  • Recent analyst commentary has been mixed to mildly positive overall, but the spread between the highest and lowest targets shows that expectations are no longer uniformly upbeat.
  • The bearish case centers on valuation: even with steady demand for household staples, analysts see less room for the stock to rerate higher after its recent move.
  • With no major company-specific catalyst in the last week, trading appears tied more to broader consumer staples sentiment and investor preference for defensive names than to fresh operating news.
Sentiment:
⚖️Neutral
Corteva

CTVA is under pressure as investors weigh breakup risk and a weak technical backdrop.

  • Analysts are flagging a lack of strong long-term support, which is weighing on sentiment and making the stock look more exposed to short-term swings.
  • Investor attention is centered on possible business split scenarios, with the market worried that separating operations could reduce synergies and value creation.
  • Broader trading signals remain soft, with bearish momentum and declining volume reinforcing the view that buyers have yet to step in convincingly.
Sentiment:
🐻Bearish

Investment Analysis

Pros

  • Reported revenue growth of 3.31% in 2024, reaching $20.10 billion, demonstrating steady top-line expansion.
  • Maintains a strong dividend yield around 2.7%, offering consistent income for investors.
  • Has a well-established global presence with diversified segments in Oral, Personal and Home Care, and Pet Nutrition.

Considerations

  • Relatively high debt-to-equity ratio raises concerns about financial leverage and risk.
  • Stock price has shown limited appreciation over the past year, which may deter growth-focused investors.
  • Valuation indicated by a P/E ratio around 22 could be considered high compared to peers, limiting upside potential.

Pros

  • Operates in the agricultural sector with exposure to crop protection and seed products, aligning with global food demand growth.
  • Has a sizable market capitalization and revenue base, supporting operational scale and resource investment.
  • Analyst sentiment includes buy recommendations, reflecting confidence in growth prospects and strategic positioning.

Considerations

  • Stock price volatility remains a concern due to commodity price sensitivity and environmental regulatory risks.
  • Exposure to cyclical agricultural markets imposes earnings unpredictability linked to weather and global trade dynamics.
  • Execution risks exist in integrating research and development to maintain competitive product pipelines.

Colgate-Palmolive (CL) Next Earnings Date

Colgate-Palmolive’s next earnings release is expected on July 31, 2026, based on the company’s usual late-July reporting pattern. The upcoming report should cover Q2 2026. If management confirms the date formally, it will likely be announced closer to the release window.

Corteva (CTVA) Next Earnings Date

Corteva’s next earnings date is July 30, 2026, based on the company’s announced schedule. The report will cover second-quarter 2026 results. The earnings release is expected after the market close, with the investor webcast scheduled for the following morning.

Buy CL or CTVA in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

CL
CL$90.00
vs
CTVA
CTVA$0.00
Buy CL